Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1

Endocrinology

Volumn 145, Issue 7, 2004, Pages 3307-3323

  Goren, H Joseph ^a,b   Kulkarni, Rohit N ^a   Kahn, C Ronald ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BODY FAT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; INBRED STRAIN; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TRANSGENE;

ADIPOSE TISSUE; AGING; ANIMALS; BLOOD GLUCOSE; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HYPOGLYCEMIC AGENTS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; MUSCLE, SKELETAL; PHENOTYPE; PHOSPHOPROTEINS; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY;

EID: 3042636409     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1400     Document Type: Article

References (67)

1. Blake JA, Richardson JE, Bult CJ, Kadin JA, Eppig JT 2003 MGD: the Mouse Genome Database. Nucleic Acids Res 31:193-195
2. Leiter EH 2002 Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions. Diabetologia 45:296-308
3. Taketo M, Schroeder AC, Mobraaten LE, Gunning KB, Hanten G, Fox RR, Roderick TH, Stewart CI, Lilly F, Hansen CT, Overbeek PA 1991 FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci USA 88:2065-2069
4. Gardner RL, Brook FA1997 Reflections on the biology of embryonic stem (ES) cells. Int J Dev Biol 41:235-243
5. Wong GT 2002 Speed congenics: applications for transgenic and knock-out mouse strains. Neuropeptides 36:230-236
6. Sigmund CD 2000 Viewpoint: are studies in genetically altered mice out of control? Arterioscler Thromb Vasc Biol 20:1425-429
7. Coleman DL 1992 The influence of genetic background on the expression of mutations at the diabetes (db) locus in the mouse. VI: Hepatic malic enzyme activity is associated with diabetes severity. Metabolism 41:1134-1136
8. Bultman S, Magnuson T 2000 Classical genetics and gene targeting. In: Joyner AL, ed. Gene targeting. 2nd ed. New York: Oxford University Press; 254-283
9. Wolfer DP, Crusio WE, Lipp HP 2002 Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci 25:336-340
10. Al-Saktawi K, McLaughlin M, Klugmann M, Schneider A, Barrie JA, McCulloch MC, Montague P, Kirkham D, Nave KA, Griffiths IR 2003 Genetic background determines phenotypic severity of the Plp rumpshaker mutation. J Neurosci Res 72:12-24
11. Kahn CR 1999 The pathogenesis of type 2 non-insulin-dependent diabetes. In: Kahn CR, ed. Diabetes. Philadelphia: Blackwell Science Inc.; 71-82
12. Baudry A, Leroux L, Jackerott M, Joshi RL 2002 Genetic manipulation of insulin signaling, action and secretion in mice. Insights into glucose homeostasis and pathogenesis of type 2 diabetes. EMBO Rep 3:323-328
13. Kahn CR, Bruning JC, Michael MD, Kulkarni RN 2000 Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes mellitus. J Pediatr Endocrinol Metab 13:1377-1384
14. Kadowaki T 2000 Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 106:459-465
15. Nakae J, Kido Y, Accili D 2001 Tissue-specific insulin resistance in type 2 diabetes: lessons from gene-targeted mice. Ann Med 33:22-27
16. Lamothe B, Baudry A, Desbois P, Lamotte L, Bucchini D, DeMeyts P, Joshi RL 1998 Genetic engineering in mice: impact on insulin signalling and action. Biochem J 335:193-204
17. Shulman GI 2000 Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176
18. Naggert JK, Mu JL, Frankel W, Bailey DW, Paigen B 1995 Genomic analysis of the C57BL/Ks mouse strain. Mamm Genome 6:131-133
19. Lueders KK 1995 Differences in intracisternal A-particle and GLN proviral loci suggest a genetic contribution from a DBA/2-like strain in generation of the C57BL/Ks strain. Mamm Genome 6:134-136
20. Del Prato S, Marchetti P, Bonadonna RC 2002 Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes 51 (Suppl 1):S109-S116
21. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR 1999 Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-339
22. Di Cola G, Cool MH, Accili D 1997 Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J Clin Invest 99:2538-2544
23. Kulkarni RN, Wang ZL, Wang RM, Hurley JD, Smith DM, Ghatei MA, Withers DJ, Gardiner JV, Bailey CJ, Bloom SR 1997 Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 100:2729-2736
24. Tsuruzoe K, Emkey R, Kriauciunas KM, Ueki K, Kahn CR 2001 Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling. Mol Cell Biol 21:26-38
25. Brandhorst BP, McConkey EH 1975 Relationship between nuclear and cytoplasmic poly(adenylic acid). Proc Natl Acad Sci USA 72:3580-3584
26. Patti M-E, Kahn CR 1998 The insulin receptor - a critical link in glucose-homeostasis and insulin action. Rev Clin Basic Pharmacol 9:89-109
27. Kulkarni RN, Michael MD, Kahn CR 2000 Tissue-specific knockouts of the insulin receptor tyrosine kinase. New York: Wiley-Liss, Inc.; 129-154
28. Mauvais-Jarvis F, Virkamaki A, Michael MD, Winnay JN, Zisman A, Kulkarni RN, Kahn CR 2000 A model to explore the interaction between muscle insulin resistance and β-cell dysfunction in the development of type 2 diabetes. Diabetes 49:2126-2134
29. Plagge A, Kelsey G, Allen ND 2000 Directed mutagenesis in embryonic stem cells. In: Jackson IJ, Abbott CM, eds. Mouse genetics and transgenics. Oxford: Oxford University Press; 247-284
30. Hammes A, Schedl A 2000 Generation of transgenic mice from plasmids, BACs and YACs. In: Jackson IJ, Abbott CM, eds. Mouse genetics and transgenics. Oxford: Oxford University Press
31. Kulkarni RN, Okada T 2002 Tissue-specific targeting of the insulin receptor gene. Endocrine 19:257-266
32. Shioi T, McMullen JR, Kang PM, Douglas PS, Obata T, Franke TF, Cantley LC, Izumo S 2002 Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol 22:2799-2809
33. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED 2002 Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109:629-639
34. Ueki K, Yballe CM, Brachmann SM, Vicent D, Watt JM, Kahn CR, Cantley LC 2002 Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase. Proc Natl Acad Sci USA 99:419-424
35. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvator P, Asico LD, Jose PA, Taylor SI, Westphal H 1996 Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12:106-109
36. Joshi RL, Lamothe B, Cordonnier N, Mesbah K, Monthioux E, Jami J, Bucchini D 1996 Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J 15:1542-1547
37. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, Satoh S, Sekihara H, Sciacchitano S, Lesniak M, Aizawa S, Nagai R, Kimura S, Akanuma Y, Taylor Si, Kadowaki T 2000 Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia. Diabetes 49:1880-1889
38. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF 1998 Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904
39. Kulkarni RN, Almind K, Goren HJ, Winnay JN, Ueki K, Okada T, Kahn CR 2003 Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice. Diabetes 52:1528-1534
40. DeFronzo RA 1988 Lilly lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687
41. Baumann CA, Saltiel AR 2001 Spatial compartmentalization of signal transduction in insulin action. Bioessays 23:215-222
42. Easom RA 2000 β-Granule transport and exocytosis. Semin Cell Dev Biol 11:253-266
43. Henquin JC 2000 Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751-1760
44. Henquin JC, Ishiyama N, Nenquin M, Ravier MA, Jonas JC 2002 Signals and pools underlying biphasic insulin secretion. Diabetes 51(Suppl 1):S60-S67
45. Leiter EH, Chapman HD, Coleman DL 1989 The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia. Endocrinology 124:912-922
46. Partridge L, Gems D 2002 Mechanisms of ageing: public or private? Nat Rev Genet 3:165-175
47. Tatar M, Bartke A, Antebi A 2003 The endocrine regulation of aging by insulin-like signals. Science 299:1346-1351
48. Bluher M, Kahn BB, Kahn CR 2003 Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299:572-574
49. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, Li H, Kenyon C 2003 Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424:277-283
50. Rizzo MA, Piston DW 2003 Regulation of β cell glucokinase by S-nitrosylation and association with nitric oxide synthase. J Cell Biol 161:243-248
51. Blachier F, Leclercq-Meyer V, Marchand J, Woussen-Colle MC, Mathias PC, Sener A, Malaisse WJ 1989 Stimulus-secretion coupling of arginine-induced insulin release. Functional response of islets to L-arginine and L-ornithine. Biochim Biophys Acta 1013:144-151
52. Kahn CR, Smth RJ, Chin WW 1998 Mechanism of action of hormones that act at the cell surface. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology. 9th ed. Philadelphia: W. B. Saunders; 95-143
53. Auboeuf D, Vidal H 1997 The use of the reverse transcription-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples. Anal Biochem 245:141-148
54. Watanabe M, Hirose Y, Sugimoto M, Nakanishi M, Watanabe H, Shimada M 1992 The distribution of tissue insulin receptors in the mouse by whole-body autoradiography. J Recept Res 12:13-37
55. Kulkarni RN, Winnay JN, Daniels M, Bruning JC, Flier SN, Hanahan D, Kahn CR 1999 Altered function of insulin receptor substrate-1-deficient mouse islets and cultured β-cell lines. J Clin Invest 104:R69-R75
56. Combatsiaris TP, Charron MJ 1999 Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment. Diabetes 48:128-133
57. Leibiger B, Wahlander K, Berggren PO, Leibiger IB 2000 Glucose-stimulated insulin biosynthesis depends on insulin-stimulated insulin gene transcription. J Biol Chem 275:30153-30156
58. Srivastava S, Goren HJ 2003 Insulin constitutively secreted by β-cells is necessary for glucose-stimulated insulin secretion. Diabetes 52:2049-2056
59. Pessin JE, Saltiel AR 2000 Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106:165-169
60. Kulkarni RN 2002 Receptors for insulin and insulin-like growth factor-1 and insulin receptor substrate-1 mediate pathways that regulate islet function. Biochem Soc Trans 30:317-322
61. Lingohr MK, Buettner R, Rhodes CJ 2002 Pancreatic β-cell growth and survival - a role in obesity-linked type 2 diabetes? Trends Mol Med 8:375-384
62. Rhodes CJ, White MF 2002 Molecular insights into insulin action and secretion. Eur J Clin Invest 32(Suppl 3):3-13
63. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR 2002 β-Cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass. Nat Genet 31:111-115
64. Xuan S, Kitamura T, Nakae J, Politi I, Kido Y, Fisher PE, Morroni M, Cinti S, White MF, Herrera PL, Accili D, Efstratiadis A 2002 Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor. J Clin Invest 110:1011-1019
65. Leiter EH, Wilson GL 1988 Viral interactions with pancreatic beta-cells. In: Lefebvre PJ, Pipeleers D, eds. The pathology of the endocrine pancreas in diabetes. Berlin: Springer Verlag; 85
66. Ranheim T, Dumke C, Schueler KL, Cartee GD, Attie AD 1997 Interaction between BTBR and C57BL/6J genomes produces an insulin resistance syndrome in (BTBR X C57BL/6J) F1 mice. Arterioscler Thromb Vasc Biol 17:3286-3293
67. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R 1997 Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) 132:107-124